Loading
companiesCompany
ModeX Therapeutics
ModeX Therapeutics is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing the tetraspecific T-cell engagers MDX2001 and MDX2003 in biliary tract cancer, cervical cancer, colorectal cancer and endometrial cancer.
Also called: ModeX Therapeutics, An OPKO Health Company
Overview
ModeX Therapeutics develops multispecific antibodies and nanoparticle vaccines for cancer and infectious disease. Its oncology pipeline includes MDX2001 (cMET x Trop2 x CD3 x CD28) for solid tumours and MDX2003 (CD19 x CD20 x CD3 x CD28) for B-cell leukaemia and lymphoma, both tetraspecific T-cell engagers. It is a wholly owned subsidiary of OPKO Health. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT06239194 (phase 1/2, Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors) and NCT07249905 (phase 1/2, Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.
Headquarters
Weston, Massachusetts, US
Type
Stage
Acquired
Website
Founded
2013
Similar pages
- InstitutionLymphoma Action
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).
- CollectionLymphoma Research Foundation (LRF)
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma.
- InstitutionAnthony Nolan
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).
- TermVaccinations around lymphoma treatment: the ones to have first, and the ones not to have at all
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).
- InstitutionBlood Cancer UK
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).
- TrialStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
Shares Waldenström macroglobulinaemia, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).
- TermGoing back to work after lymphoma, and the money in the meantime
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).
- TermA clinical trial or standard treatment in lymphoma
Shares Waldenström macroglobulinaemia, Follicular lymphoma, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types).